Piramal’s Buyout Of Minrad May Dent Strongholds Of Abbott, Baxter
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Abbott and Baxter are set to face strong competition in their traditional businesses of hospital anesthetic gas products as India's Piramal Healthcare has announced its acquisition of U.S. based Minrad International, a provider of generic inhalation anesthetics that include isoflurane, enflurane and sevoflurane. In addition, Minrad has filed an abbreviated new drug application for desflurane with U.S. FDA